| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |